Free Trial

Lemonade (LMND) Expected to Announce Earnings on Tuesday

Lemonade logo with Finance background

Lemonade (NYSE:LMND - Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Tuesday, April 29th. Analysts expect Lemonade to post earnings of ($0.95) per share and revenue of $144.98 million for the quarter. Lemonade has set its FY 2025 guidance at EPS and its Q1 2025 guidance at EPS.

Lemonade (NYSE:LMND - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported ($0.42) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.61) by $0.19. The business had revenue of $148.80 million for the quarter, compared to analysts' expectations of $144.78 million. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. On average, analysts expect Lemonade to post $-3 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Lemonade Trading Up 0.5 %

Shares of Lemonade stock traded up $0.16 on Friday, hitting $29.54. 1,098,432 shares of the company traded hands, compared to its average volume of 1,925,695. The firm's 50-day simple moving average is $31.83 and its 200 day simple moving average is $33.53. The company has a market cap of $2.15 billion, a P/E ratio of -9.72 and a beta of 2.13. Lemonade has a 12-month low of $14.03 and a 12-month high of $53.85.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on LMND. Morgan Stanley cut shares of Lemonade from an "equal weight" rating to an "underweight" rating and lowered their price objective for the company from $35.00 to $24.00 in a research report on Tuesday, April 8th. Keefe, Bruyette & Woods lowered their price objective on shares of Lemonade from $25.00 to $22.00 and set an "underperform" rating on the stock in a research report on Tuesday, April 22nd. Finally, Piper Sandler lowered their price objective on shares of Lemonade from $44.00 to $34.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Four research analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $28.17.

Check Out Our Latest Report on LMND

Insider Activity at Lemonade

In other Lemonade news, major shareholder Softbank Group Capital Ltd sold 42,160 shares of the firm's stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of $37.22, for a total value of $1,569,195.20. Following the sale, the insider now owns 10,452,476 shares of the company's stock, valued at $389,041,156.72. This trade represents a 0.40 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider John Sheldon Peters sold 1,899 shares of the firm's stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $33.79, for a total transaction of $64,167.21. Following the completion of the sale, the insider now directly owns 87,609 shares in the company, valued at approximately $2,960,308.11. This trade represents a 2.12 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 248,634 shares of company stock valued at $9,219,003. Insiders own 12.50% of the company's stock.

Lemonade Company Profile

(Get Free Report)

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.

Read More

Earnings History for Lemonade (NYSE:LMND)

Should You Invest $1,000 in Lemonade Right Now?

Before you consider Lemonade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.

While Lemonade currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines